You searched for "atrophy"
Occult central retinal artery occlusion
Central retinal artery occlusion (CRAO) is a sight-threatening condition resulting from occlusion of the central retinal artery and hypoperfusion of the inner retina. Early on, fundal examination may be normal. The authors present a retrospective case series of 11 patients...AI insights lead OSA lecture programme
Ophthalmology’s role at the forefront of many areas of healthcare, providing valuable insights to early disease markers and progression, is to be highlighted on the OSA stand at 100% Optical. Some seven hours of free to attend lectures will provide a vision of the next five years of High Street practice.Transforming eyecare with AI at 100% Optical
“We are drowning in people we need to see in hospital eye services, and some people are going blind as a result. We are looking at nearly 10m hospital appointments for ophthalmology a year, with an approximately 33% increase over...A life less miserable
Secret reveal… I love musicals! Ignoring regular derision from high-brow critics, musical theatre continues to maintain a strong presence in the hearts and minds of the people. Broadway and the West End thrive with new shows and classic productions entertaining...Feb/Mar 2015 Quiz 1
A 79-year-old male presented to the ophthalmic emergency department with a three week history of left eye pain. He also reported visual deterioration in the left eye over the same period. He suffered from degenerative myopia, with his spectacle prescription...UKISCRS 47th Annual Congress Preview
Check out the Eye News preview for UKISCRS' 47th Annual Congress in London, 1-3 November.Blind Inverclyde woman finds her voice
Claire Forde (29) from Greenock is no stranger to a microphone. Her journey into public speaking took a major step forward this year when she joined a newly launched Speakers Club, created to improve the confidence and communication skills of...Neovascular AMD: fresh recommendations underline standards of best practice
The management of neovascular age-related macular degeneration (nAMD) has advanced dramatically over the past seven years, with the introduction of targeted new therapies that successfully maintain or improve vision in a majority of affected individuals. It’s a fast moving field,...Corporate M&A pace gathers momentum
Intensifying franchise competition, maturing product development pipelines and looming loss of exclusivity spur renewed merger and acquisition (M&A) activity in the ophthalmics sector. Rod McNeil reviews recent deals and related strategic developments. AbbVie to acquire Allergan in $63 billion mega-combination,...
Atropine treatment for myopia in western countries – rationale
This preliminary study sets out the rationale, methodology and participant baseline characteristics for the Western Australia Atropine for the Treatment of Myopia (WA-ATOM). It is a double masked randomised placebo-controlled trial. This study is designed to be combined with the...
